相关实验视频
Updated: Jun 13, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
418
代谢效应 - 解读癌症中的脂质代谢如何与瘤微环境接口
Patrick B Jonker1, Alexander Muir1
1Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
Disease models & mechanisms
|September 16, 2024
概括
癌细胞依赖脂质才能生存. 瘤微环境显著影响癌症脂质代谢,通过影响这些必需的营养物质获取途径,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 脂质对癌细胞平衡,生长,生存和能量生产至关重要.
- 瘤脂质获取是开发癌症治疗方法的关键研究领域.
- 癌症脂质代谢对瘤微环境的影响非常敏感.
研究的目的:
- 审查由瘤微环境决定的瘤脂质获取机制.
- 探索瘤微环境衍生的脂质可用性如何影响各种癌症代谢途径.
- 讨论在瘤微环境中识别癌细胞脂质需求的新工具.
主要方法:
- 关于瘤脂质代谢和微环境相互作用的文献综述.
- 分析关于脂质可用性及其在癌症中的代谢后果的新兴研究.
- 讨论用于表征瘤脂质要求的新方法.
主要成果:
- 瘤微环境积极塑造癌细胞的脂质代谢途径.
- 瘤微环境中的脂质可用性会在癌细胞中引发广泛的代谢变化,超出脂质生物学范围.
- 这些代谢变化在癌细胞的相互连接的代谢网络中产生""效应.
结论:
- 了解瘤微环境驱动的脂质代谢对于癌症治疗至关重要.
- 准脂质获取途径是一个有前途的治疗策略.
- 新的工具对于充分描述瘤代谢和微观环境之间的复杂相互作用至关重要.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

